Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $110.8400 (3.99%) ($106.8200 - $113.0000) on Tue. Dec. 29, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 52 | Latest Price | $110.8400(3.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) XBI(57%) IWO(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.395% in a week (0% probabilities). VIXM(-17%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | 0 () | Intraday Trend | 3.3% | | | |
|
5 Day Moving Average | $108.1(2.53%) | 10 Day Moving Average | $108.76(1.91%) | 20 Day Moving Average | $107.74(2.88%) | To recent high | -0.9% | To recent low | 35% | Market Cap | $1.781b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |